John Oyler insider trades: BeOne Medicines (ONC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
81 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | ONC | ↓ Sell | 240,810 | $359.12 | $86.5M | Direct | Aug 12, 2026 (0d) |
| Jul 21, 2026 | ONC | ↓ Sell | 109,713 | $315.28 | $34.6M | Direct | Jul 22, 2026 (1d) |
| Jul 17, 2026 | ONC | ↓ Sell | 64,628 | $312.00 | $20.2M | Direct | Jul 17, 2026 (0d) |
| Jul 16, 2026 | ONC | ↓ Sell | 283,154 | $315.56 | $89.4M | Direct | Jul 17, 2026 (1d) |
| Jul 14, 2026 | ONC | ↓ Sell | 145,861 | $305.95 | $44.6M | Direct | Jul 14, 2026 (0d) |
| Jul 13, 2026 | ONC | ↓ Sell | 60,218 | $303.18 | $18.3M | Direct | Jul 14, 2026 (1d) |
| Jun 16, 2026 | ONC | ↓ Sell | 3,693 | $265.55 | $981K | Direct | Jun 18, 2026 (2d) |
| Jun 11, 2026 | ONC | ↓ Sell | 1,949 | $257.24 | $501K | Direct | Jun 15, 2026 (4d) |
| Jun 8, 2026 | ONC | ↓ Sell | 4,940 | $270.56 | $1.3M | Direct | Jun 10, 2026 (2d) |
| Dec 16, 2025 | ONC | ↓ Sell | 100,000 | $306.59 | $30.7M | Direct | Dec 17, 2025 (1d) |
| Sep 16, 2025 | ONC | ↓ Sell | 27,803 | $325.71 | $9.1M | Direct | Sep 18, 2025 (2d) |
| Jul 9, 2025 | ONC | ↓ Sell | 27,802 | $253.38 | $7.0M | Direct | Jul 11, 2025 (2d) |
| Jun 23, 2025 | ONC | ↓ Sell | 3,174 | $261.61 | $830K | Direct | Jun 25, 2025 (2d) |
| Jun 17, 2025 | ONC | ↓ Sell | 5,140 | $263.33 | $1.4M | Direct | Jun 18, 2025 (1d) |
| Jun 6, 2025 | ONC | ↓ Sell | 5,127 | $252.77 | $1.3M | Direct | Jun 10, 2025 (4d) |
| Mar 10, 2025 | BGNE | ↓ Sell | 41,210 | $242.67 | $10.0M | Direct | Mar 12, 2025 (2d) |
| Mar 7, 2025 | BGNE | ↓ Sell | 58,590 | $249.13 | $14.6M | Direct | Mar 7, 2025 (0d) |
| Mar 6, 2025 | BGNE | ↓ Sell | 40,109 | $259.15 | $10.4M | Direct | Mar 7, 2025 (1d) |
| Mar 3, 2025 | BGNE | ↓ Sell | 101,000 | $244.30 | $24.7M | Direct | Mar 5, 2025 (2d) |
| Oct 8, 2024 | BGNE | ↓ Sell | 10,000 | $232.22 | $2.3M | Indirect | Oct 10, 2024 (2d) |
| Oct 8, 2024 | BGNE | ↓ Sell | 6,175 | $232.22 | $1.4M | Direct | Oct 10, 2024 (2d) |
| Jun 24, 2024 | BGNE | ↓ Sell | 2,789 | $159.58 | $445K | Direct | Jun 26, 2024 (2d) |
| Jun 17, 2024 | BGNE | ↓ Sell | 1,281 | $159.35 | $204K | Direct | Jun 20, 2024 (3d) |
| Apr 11, 2024 | BGNE | ↓ Sell | 50,000 | $149.50 | $7.5M | Indirect | Apr 11, 2024 (0d) |
| Mar 13, 2024 | BGNE | ↓ Sell | 50,000 | $167.36 | $8.4M | Direct | Mar 14, 2024 (1d) |
| Jan 10, 2023 | BGNE | ↓ Sell | 13,594 | $248.51 | $3.4M | Indirect | Jan 12, 2023 (2d) |
| Jan 10, 2023 | BGNE | ↓ Sell | 6,797 | $248.52 | $1.7M | Direct | Jan 12, 2023 (2d) |
| Dec 29, 2022 | BGNE | ↓ Sell | 6,406 | $224.43 | $1.4M | Indirect | Dec 29, 2022 (0d) |
| Dec 29, 2022 | BGNE | ↓ Sell | 3,203 | $224.43 | $719K | Direct | Dec 29, 2022 (0d) |
| Nov 15, 2022 | BGNE | ↓ Sell | 25,000 | $206.84 | $5.2M | Direct | Nov 17, 2022 (2d) |
| Nov 15, 2022 | BGNE | ↓ Sell | 4,928 | $206.82 | $1.0M | Indirect | Nov 17, 2022 (2d) |
| Sep 21, 2022 | BGNE | ↓ Sell | 48,950 | $152.11 | $7.4M | Indirect | Sep 22, 2022 (1d) |
| Sep 15, 2021 | BGNE | ↓ Sell | 64,035 | $371.14 | $23.8M | Direct | Sep 16, 2021 (1d) |
| Sep 15, 2021 | BGNE | ↓ Sell | 347,803 | $28.82 | $10.0M | Direct | Sep 16, 2021 (1d) |
| Sep 2, 2021 | BGNE | ↓ Sell | 84,281 | $317.54 | $26.8M | Direct | Sep 2, 2021 (0d) |
| Sep 1, 2021 | BGNE | ↓ Sell | 204,358 | $24.09 | $4.9M | Direct | Sep 2, 2021 (1d) |
| Aug 5, 2021 | BGNE | ↓ Sell | 42,109 | $342.51 | $14.4M | Direct | Aug 5, 2021 (0d) |
| Aug 5, 2021 | BGNE | ↓ Sell | 83,200 | $25.97 | $2.2M | Direct | Aug 5, 2021 (0d) |
| Aug 3, 2021 | BGNE | ↓ Sell | 41,959 | $337.48 | $14.2M | Direct | Aug 5, 2021 (2d) |
| Aug 3, 2021 | BGNE | ↓ Sell | 41,400 | $25.17 | $1.0M | Direct | Aug 5, 2021 (2d) |
| Jul 22, 2021 | BGNE | ↓ Sell | 11,316 | $317.98 | $3.6M | Direct | Jul 22, 2021 (0d) |
| Jul 22, 2021 | BGNE | ↓ Sell | 57,900 | $23.71 | $1.4M | Direct | Jul 22, 2021 (0d) |
| Jul 21, 2021 | BGNE | ↓ Sell | 31,255 | $313.70 | $9.8M | Direct | Jul 22, 2021 (1d) |
| Jul 21, 2021 | BGNE | ↓ Sell | 39,600 | $24.60 | $974K | Direct | Jul 22, 2021 (1d) |
| Jul 8, 2021 | BGNE | ↓ Sell | 16,181 | $318.62 | $5.2M | Direct | Jul 8, 2021 (0d) |
| Jul 8, 2021 | BGNE | ↓ Sell | 51,300 | $24.24 | $1.2M | Direct | Jul 8, 2021 (0d) |
| Jul 7, 2021 | BGNE | ↓ Sell | 38,821 | $318.52 | $12.4M | Direct | Jul 8, 2021 (1d) |
| Jul 7, 2021 | BGNE | ↓ Sell | 85,000 | $25.29 | $2.1M | Direct | Jul 8, 2021 (1d) |
| Sep 29, 2020 | BGNE | ↓ Sell | 54,303 | $280.39 | $15.2M | Direct | Sep 30, 2020 (1d) |
| Sep 16, 2020 | BGNE | ↓ Sell | 81,228 | $253.46 | $20.6M | Direct | Sep 16, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ONC insiders
Open-market trades in the last 12 months
About John Oyler's insider trades
John Oyler is Chief Executive Officer at BeOne Medicines (ONC). Since Feb 21, 2017, John has reported no open-market purchases and 81 sales worth $813.0M on SEC Form 4. In the last 12 months: 10 sales ($326.9M).
Their filings also include grants and awards (14 filings), option exercises (12 filings), gifts (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ONC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.